aspartic acid has been researched along with alprostadil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| De Luca, V; Monda, M; Sullo, A; Viggiano, A | 1 |
| Bowman, BM; Kopecek, J; Kopecková, P; Miller, SC; Pan, H; Wang, D | 1 |
3 other study(ies) available for aspartic acid and alprostadil
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Aspartic and glutamic acids increase in the frontal cortex during prostaglandin E1 hyperthermia.
Topics: Adipose Tissue, Brown; Alprostadil; Animals; Aspartic Acid; Body Temperature Regulation; Colon; Fever; Frontal Lobe; Glutamic Acid; Injections, Intraventricular; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 1998 |
Feasibility of using a bone-targeted, macromolecular delivery system coupled with prostaglandin E(1) to promote bone formation in aged, estrogen-deficient rats.
Topics: Aging; Alprostadil; Animals; Aspartic Acid; Drug Delivery Systems; Estrogens; Female; Fluorescein-5-isothiocyanate; Methacrylates; Oligopeptides; Osteogenesis; Rats; Rats, Sprague-Dawley | 2008 |